News Releases

Decade of TMV research leads to never-before-seen microsystems for energy storage, biosensors and self-sustaining systems

Submitted by IBBR Webmaster on June 21, 2017 - 10:38

Since 2007, University of Maryland professors Reza Ghodssi (Electrical and Computer Engineering and Institute for Systems Research) and James Culver (Plant Sciences and Landscape Architecture and Institute of Bioscience and Biotechnology Research) have partnered with colleagues from materials science, chemistry and bioengineering to create devices using the Tobacco mosaic virus as a biological nanoscaffold.

IBBR Awarded $6 Million NIH Grant for Structure-Based Design of a Hepatitis C Vaccine

Submitted by Vicki Buckholz on June 12, 2017 - 10:06

(Rockville, MD, June 12, 2017) University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $6.0 million grant entitled, “Structure-Based Vaccine Design for Hepatitis C Virus”, to develop a novel prophylactic vaccine to prevent hepatitis C virus (HCV) infection. The grant is funded by the National Institutes of Health (NIH) and the research will take place over a five-year period.  

IBBR faculty win two Maryland Innovation Initiative (MII) grants

Submitted by Vicki Buckholz on June 5, 2017 - 14:07

(Rockville, Maryland) The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded two $115,000 grants to commercialize technologies based on improving protein-based therapeutics utilizing a novel biopolymer and an alternate way to treat Niemann-Pick disease patients. The grants are funded by the Maryland Innovation Initiative (MII) as part of the Technology Council of Maryland’s (TEDCO) effort to support commercialization of academic-based scientific research and the state’s efforts to foster economic development in Maryland.

Genisphere Begins Collaborative and Sponsored Research Program with the University of Maryland

Submitted by Tiffany Stone on April 20, 2017 - 10:20

HATFIELD, Pa - April 26, 2017 - Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia Muro. The overall goal of the partnership is to study the pharmacokinetics and pharmacodynamics of various 3DNA designs and formulations after in vivo administration.

IBBR Receives Award to Develop Drought-Tolerant Plants

Submitted by Tiffany Stone on February 21, 2017 - 14:14

(Rockville, Maryland) The Institute for Bioscience and Biotechnology Research has been awarded a $100,000 grant to test the broader applicability of a technology platform invented by one of its leading scientists towards engineering drought-tolerant, agriculturally important crops.  The grant is funded by the Maryland Innovation Initiative (MII) as part of the Technology Council of Maryland’s (TEDCO) effort to support commercialization of academic-based scientific research as part of the state’s efforts to foster economic development in Maryland.

Bentley Leads Team of Researchers Working to Develop Electrogenetic Device for Activating Gene Expression via Electrodes

Submitted by Tiffany Stone on January 17, 2017 - 12:16

FOR IMMEDIATE RELEASE   
                                               

Media Contact: Alyssa Wolice, 301-405-3936
 

UMD Researchers Develop Electrogenetic Device for Activating Gene Expression via Electrodes

System Holds Promise for Study of Biological Systems, Biosensors and Bio-hybrid Devices

 

IBBR Scientist Brian Pierce Wins Best Inventor Pitch at UMD's Bioscience Day 2016

Submitted by Tiffany Stone on December 7, 2016 - 11:34

By Tiffany Stone

At the University of Maryland’s Bioscience Day 2016, Brian Pierce, PhD., Assistant Professor, Institute for Bioscience and Biotechnology Research (IBBR), presented new rational design approaches to develop hepatitis C vaccines, winning the best inventor pitch. Pierce received a $3,000 award sponsored by UM Ventures, a joint initiative of the MPowering the State Program, that brings together the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technology.